science

Mirdametinib

Mirdametinib is a science topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Mirdametinib rather than just read about it. In short: Mirdametinib, sold under the brand name Gomekli, is a medication used for the treatment of people with neurofibromatosis type 1. Mirdametinib is a kinase inhibitor.

Key takeaways

Mirdametinib belongs to science; place it in that map before memorising details.
Learn the definition first, then one example that makes the definition concrete.
Connect Mirdametinib to a quantity you can measure, compute or draw — that is where exam questions come from.
Reproduce the core statement of Mirdametinib from memory before moving on to harder problems.

Reference excerpt

Mirdametinib, sold under the brand name Gomekli, is a medication used for the treatment of people with neurofibromatosis type 1. Mirdametinib is a kinase inhibitor. It is taken by mouth. Mirdametinib was approved for medical use in the United States in February 2025.

Medical uses Mirdametinib is indicated for the treatment of people with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas not amenable to complete resection.

Adverse effects The most common adverse reactions in adults include rash, diarrhea, nausea, musculoskeletal pain, vomiting, and fatigue. The most common grade 3 or 4 laboratory abnormalities include increased creatine phosphokinase. The most common adverse reactions in children include rash, diarrhea, musculoskeletal pain, abdominal pain, vomiting, headache, paronychia, left ventricular dysfunction, and nausea. The most common grade 3 or 4 laboratory abnormalities include decreased neutrophil count and increased creatine phosphokinase. Mirdametinib can cause left ventricular dysfunction and ocular toxicity including retinal vein occlusion, retinal pigment epithelial detachment, and blurred vision.

History The efficacy of mirdametinib was evaluated in ReNeu (NCT03962543), a multicenter, single-arm trial in 114 participants aged two years of age and older (58 adults, 56 pediatric participants) with symptomatic, inoperable NF1-associated plexiform neurofibromas causing significant morbidity. An inoperable plexiform neurofibromas was defined as a plexiform neurofibromas that could not be completely surgically removed without risk for substantial morbidity due to encasement or close proximity to vital structures, invasiveness, or high vascularity. The US Food and Drug Administration (FDA) granted the application for mirdametinib priority review, fast track, and orphan drug designations along with a priority review voucher.

Society and culture

Legal status Mirdametinib was approved for medical use in the United States in February 2025. In May 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a conditional marketing authorization for the medicinal product Ezmekly, intended for the treatment of plexiform neurofibromas (PN) in adults and children from two years of age with neurofibromatosis type 1 (NF1). The applicant for this medicinal product is SpringWorks Therapeutics Ireland Limited. Mirdametinib was authorized for medical use in the EU in July 2025.

References

External links "Mirdametinib (Code C52195)". NCI Thesaurus. Archived from the original on 12 July 2009. Clinical trial number NCT03962543 for "MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform Neurofibromas (ReNeu)" at ClinicalTrials.gov

Illustrations

Worked examples

Example 1 — a first encounter with Mirdametinib

Start with the simplest possible case. Write down what Mirdametinib claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In science, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Mirdametinib before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Mirdametinib ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Mirdametinib

In research: Mirdametinib appears in science research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry: Engineering practice reuses Mirdametinib in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom: Mirdametinib is common in secondary-school and first-year university syllabi. It links to neighbouring topics Anilines, Benzamides, Fluorobenzene derivatives, so understanding it makes those chapters shorter.
In everyday life: Look for Mirdametinib outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Ask Teacher Smith questions about this articleOpens your AI tutor with a question about “Mirdametinib” →

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Mirdametinib in 20 minutes

Read the reference excerpt below once, without taking notes.
Close the page and write down what Mirdametinib means in your own words.
Compare your version with the excerpt and mark what you missed.
Work through the three examples above with pen and paper.
Explain Mirdametinib out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Mirdametinib in simple terms?

Mirdametinib, sold under the brand name Gomekli, is a medication used for the treatment of people with neurofibromatosis type 1. Mirdametinib is a kinase inhibitor.

Why does Mirdametinib matter?

Because it connects several science ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Mirdametinib?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Mirdametinib.